Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma

Ann Hematol. 2011 Jan;90(1):111-2. doi: 10.1007/s00277-010-0962-9. Epub 2010 Apr 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Common Variable Immunodeficiency / chemically induced
  • Common Variable Immunodeficiency / complications
  • Female
  • Hepatitis B / chemically induced*
  • Hepatitis B / complications
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Humans
  • Lymphoma / complications
  • Lymphoma / drug therapy*
  • Lymphoma / immunology
  • Lymphoma / virology
  • Rituximab
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab